Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2010
08/19/2010US20100209500 Controlled release budesonide minitablets
08/19/2010US20100209499 Solid Oral Dosage Form Containing an Enhancer
08/19/2010US20100209498 Pharmaceutical compositions of duloxetine
08/19/2010US20100209497 Formulations for treating human and animal diseases
08/19/2010US20100209496 Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
08/19/2010US20100209495 Granulates, process for preparing them and pharmaceutical products containing them
08/19/2010US20100209494 Liposomes and Uses Thereof
08/19/2010US20100209493 HLA-A2 Tumor Associated Antigen Peptides and Compositions
08/19/2010US20100209492 Targeted Liposomal Drug Delivery System
08/19/2010US20100209491 Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcv
08/19/2010US20100209490 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
08/19/2010US20100209489 Formulations of desvenlafaxine
08/19/2010US20100209488 Protein kinase modulating compounds and methods for making and using them
08/19/2010US20100209487 Nicked or gapped nucleic acid molecules and uses thereof
08/19/2010US20100209486 Method of enhancing CoenzymeQ10 levels in mammals
08/19/2010US20100209485 Stabilizing alkylglycoside compositions and methods thereof
08/19/2010US20100209484 Transdermal Triptan Delivery System
08/19/2010US20100209483 Transdermal delivery of meptazinol
08/19/2010US20100209482 Dressing securing system
08/19/2010US20100209481 New wound dressing compositions
08/19/2010US20100209480 Galenical formulations of organic compounds
08/19/2010US20100209479 Compositions And Methods For Treating Cancer
08/19/2010US20100209471 Medical devices having polymeric nanoporous coatings for controlled therapeutic agent delivery and a nonpolymeric macroporous protective layer
08/19/2010US20100209470 Demineralized bone matrix devices
08/19/2010US20100209468 Implantable devices for producing insulin
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209461 Purified component of blue-green algae and method of use
08/19/2010US20100209460 Anti-odor agent having disinfecting or bactericidal effect
08/19/2010US20100209459 Alkaloid formulations
08/19/2010US20100209458 Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly
08/19/2010US20100209392 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
08/19/2010US20100209370 Skin treatment composition
08/19/2010US20100209359 Medicated chewing gum
08/19/2010US20100209358 Method of Making Particles For Use In A Pharmaceutical Composition
08/19/2010US20100209357 Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors
08/19/2010US20100209353 Tumor targeting protein conjugate and a method for preparing the same
08/19/2010US20100209351 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010DE102009008851A1 Transdermal system, useful for treating multiple sclerosis and Crohn's disease, comprises an immunomodulator comprising e.g. quinoline, active agent impermeable protective layer, active agent reservoir and a carrier
08/19/2010DE102009008478A1 Vorrichtung und Verfahren zur Herstellung pharmazeutisch hochfeiner Partikel sowie zur Beschichtung solcher Partikel in Mikroreaktoren Apparatus and method for preparing pharmaceutically very fine particles and to coat such particles in microreactors
08/19/2010DE102009008186A1 Feste orale pharmazeutische Zusammensetzung umfassend einen hydrophoben Wirkstoff A solid oral pharmaceutical composition comprising a hydrophobic drug
08/19/2010DE102009008185A1 Zusammensetzung umfassend einen hydrophoben Wirkstoff sowie ein Phospholipid A composition comprising a hydrophobic drug and a phospholipid
08/19/2010DE102009008094A1 In situ Haft-Gelbildende Zubereitungen, insbesondere zur topischen Anwendung auf befeuchtete Haut/Schleimhaut In situ-gel-forming adhesive preparations, in particular for topical application to wetted skin / mucosa
08/19/2010CA2752437A1 Antidiabetic medications
08/19/2010CA2752435A1 Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/19/2010CA2752206A1 Valproic acid drug delivery systems and intraocular therapeutic uses thereof
08/19/2010CA2752160A1 Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-.beta. superfamily members
08/19/2010CA2752157A1 Peripheral administration of proteins including tgf-.beta. superfamily members for systemic treatment of disorders and disease
08/19/2010CA2752069A1 Composition comprising biodegradable carrier for controlled drug delivery
08/19/2010CA2752048A1 Delayed release, oral dosage compositions that contain amorphous cddo-me
08/19/2010CA2751703A1 Hard capsule
08/19/2010CA2751625A1 Device and method for producing pharmaceutically highly refined particles and for coating said particles in microreactors
08/19/2010CA2751449A1 Foamable microemulsion compositions for topical administration
08/19/2010CA2751271A1 A composition for buccal absorption of nicotine for the purpose of smoking cessation
08/19/2010CA2750242A1 Drug delivery through hydrogel plugs
08/19/2010CA2749091A1 Textile article for patients affected by a skin disease
08/19/2010CA2726230A1 The stabilisation of proteins
08/18/2010EP2218718A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
08/18/2010EP2218460A2 Quality control methods for oil-in-water emulsions containing squalene
08/18/2010EP2218459A1 Sustained release composition containing sdf-1
08/18/2010EP2218448A2 Oral drug delivery system comprising high viscosity liquid carrier materials
08/18/2010EP2218447A1 Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
08/18/2010EP2218446A1 Method for producing microcapsule using solid fat
08/18/2010EP2218445A1 A microparticle containing a microorganism or biological material, and a process for producing the same
08/18/2010EP2218444A2 Delayed release rasagiline formulation
08/18/2010EP2218443A1 Orally disintegrating tablet
08/18/2010EP2218442A1 Methods, compositions, and kits for the treatment of ophthalmic disorders
08/18/2010EP2218424A1 Intraocular drug delivery systems
08/18/2010EP2217363A1 Device and method for preparing microparticles
08/18/2010EP2217360A1 Apparatus and process for continuously producing spherical powder agglomerates
08/18/2010EP2217278A1 Dry powder formulations comprising ascorbic acid derivates
08/18/2010EP2217272A1 Immunotherapeutic method for increasing groundnut tolerance in a subject
08/18/2010EP2217266A2 A method for treating ailments of the oral cavity with a krill enzyme composition
08/18/2010EP2217257A2 A standardized plant extract, process for obtaining the same and uses thereof
08/18/2010EP2217241A2 Wet granulation using a water sequestering agent
08/18/2010EP2217228A1 Solid pharmaceutical composition comprising tamsulosin
08/18/2010EP2217225A2 Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
08/18/2010EP2217222A1 Method and compositions for cutaneous immunisation
08/18/2010EP2217220A1 Lipoic acid pellet composition
08/18/2010EP2217219A2 A sublingual effervescent tablet of progesterone associated with cyclodextrin
08/18/2010EP2217218A1 Improved tablet coating
08/18/2010EP2217217A1 Controlled release pharmaceutical compositions of pregabalin
08/18/2010EP2217215A1 Coated pharmaceutical compositions
08/18/2010EP2217214A2 Pharmaceutical formulation comprising ezetimibe
08/18/2010EP2217213A2 Orally disintegrative dosage form
08/18/2010EP2217212A1 Pharmaceutical solid hybrids
08/18/2010EP2217211A1 An orally-absorbed solid dose formulation for vancomycin
08/18/2010EP2217210A2 Sustained release tablets with hydromorphone
08/18/2010EP2217209A1 Novel thermosensitive liposomes containing therapeutic agents
08/18/2010EP2217208A2 Nucleic acid complex and nucleic acid delivery composition
08/18/2010EP2217207A1 Fast release solid formulation, preparation and use thereof
08/18/2010EP2217206A2 Transdermal therapeutic system having a content of a modulator for nicotinic acetylcholine receptors (nachr)
08/18/2010EP2217205A1 Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor
08/18/2010EP2217204A2 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations
08/18/2010EP2058329B1 Improved secretion of neublastin
08/18/2010EP1957041B1 Oil-in-water emulsion and its use for the delivery of functionality
08/18/2010EP1928459B1 Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo
08/18/2010EP1874314B1 Pellet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo
08/18/2010EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
08/18/2010EP1443899B1 Bowel cleansing agent
1 ... 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 ... 2991